PDI, Inc. PDII today announced that its seasonal sales services agreement with a Top 10 pharmaceutical company has been renewed for an additional season. The pharmaceutical company will continue to utilize PDI's Shared Sales team beginning in September 2011 through March 2012 to reach pediatric and primary care physicians.
This initiative is expected to generate approximately $11 million in revenue for PDI during the Fall 2011 through Spring 2012 promotional season, $6 million of which will be realized in 2011.
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in